{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:13Z","timestamp":1786119433265,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/mnm.0b013e328313b7bc","type":"journal-article","created":{"date-parts":[[2010,1,27]],"date-time":"2010-01-27T01:48:40Z","timestamp":1264556920000},"page":"30-36","source":"Crossref","is-referenced-by-count":39,"title":["Preliminary study of carbon-11 methionine PET in the evaluation of early response to therapy in advanced breast cancer"],"prefix":"10.1097","volume":"30","author":[{"given":"Paula","family":"Lindholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lapela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"N\u00e5gren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pertti","family":"Lehikoinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Minn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirkku","family":"Jyrkki\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210212","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0959-8049(02)00011-4","article-title":"Guidelines on endocrine therapy of breast cancer. EUSOMA","volume":"38","author":"Blamey","year":"2002","journal-title":"Eur J Cancer"},{"key":"R2-6-20210212","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.1993.11.11.2101","article-title":"Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation","volume":"11","author":"Wahl","year":"1993","journal-title":"J Clin Oncol"},{"key":"R3-6-20210212","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/bjc.1993.143","article-title":"Carbon-11-methionine and PET in evaluation of treatment response of breast cancer","volume":"67","author":"Huovinen","year":"1993","journal-title":"Br J Cancer"},{"key":"R4-6-20210212","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.1995.13.6.1470","article-title":"Positron emission tomography studies in patients with locally advanced and\/or metastatic breast cancer: a method for early therapy evaluation?","volume":"13","author":"Jansson","year":"1995","journal-title":"J Clin Oncol"},{"key":"R5-6-20210212","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1200\/JCO.2000.18.8.1676","article-title":"Positron emission tomography using [18F]fluorodeoxy-D-glucose to predict the pathological response of breast cancer to primary chemotherapy","volume":"18","author":"Smith","year":"2000","journal-title":"J Clin Oncol"},{"key":"R6-6-20210212","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.2000.18.8.1689","article-title":"Positron emission tomography using [18F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer.","volume":"18","author":"Schelling","year":"2000","journal-title":"J Clin Oncol"},{"issue":"1","key":"R7-6-20210212","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1007\/s00259-004-1532-y","article-title":"Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations","volume":"31","author":"Krak","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"R8-6-20210212","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1007\/s00259-004-1533-x","article-title":"FDG-PET in monitoring therapy of breast cancer","volume":"31","author":"Biersack","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-6-20210212","first-page":"1144","article-title":"Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET","volume":"46","author":"Schwarz","year":"2005","journal-title":"J Nucl Med"},{"key":"R10-6-20210212","first-page":"1472","article-title":"Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors","volume":"37","author":"Inoue","year":"1996","journal-title":"J Nucl Med"},{"key":"R11-6-20210212","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/02841869109092438","article-title":"The biology of human cancer metastasis","volume":"30","author":"Fidler","year":"1991","journal-title":"Acta Oncol"},{"key":"R12-6-20210212","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1200\/JCO.1998.16.12.3720","article-title":"Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial","volume":"16","author":"Joensuu","year":"1998","journal-title":"J Clin Oncol"},{"key":"R13-6-20210212","first-page":"557","article-title":"Cancer. Principles and practice of oncology","author":"Harris","year":"1997"},{"key":"R14-6-20210212","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R15-6-20210212","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2004.08.181","article-title":"Bone imaging in metastatic breast cancer","volume":"22","author":"Hamaoka","year":"2004","journal-title":"J Clin Oncol"},{"key":"R16-6-20210212","first-page":"1037","article-title":"Synthesis of L- and D-[methyl-11C]methionine","volume":"28","author":"L\u00e5ngstr\u00f6m","year":"1987","journal-title":"J Nucl Med"},{"key":"R17-6-20210212","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/00004728-199205000-00023","article-title":"[11C]Methionine quantitation in cancer PET studies","volume":"16","author":"Leskinen-Kallio","year":"1992","journal-title":"J Comput Assist Tomogr"},{"key":"R18-6-20210212","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","article-title":"Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations","volume":"35","author":"Young","year":"1999","journal-title":"Eur J Cancer"},{"key":"R19-6-20210212","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/bjc.1991.475","article-title":"Uptake of 11C-methionine in breast cancer studied by PET. An association with the size of S-phase fraction","volume":"64","author":"Leskinen-Kallio","year":"1991","journal-title":"Br J Cancer"},{"key":"R20-6-20210212","first-page":"46","article-title":"Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer","volume":"43","author":"Nu\u00f2ez","year":"2002","journal-title":"J Nucl Med"},{"key":"R21-6-20210212","first-page":"1980","article-title":"Nodal staging of lymphoma with whole-body PET: comparison of [11C]methionine and FDG","volume":"41","author":"Sutinen","year":"2000","journal-title":"J Nucl Med"},{"key":"R22-6-20210212","first-page":"431","article-title":"Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast cancer","volume":"39","author":"Moon","year":"1998","journal-title":"J Nucl Med"},{"key":"R23-6-20210212","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1200\/JCO.1998.16.1.173","article-title":"Preclinical and clinical studies of bone marrow uptake of fluorine-18-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy","volume":"16","author":"Sugawara","year":"1998","journal-title":"J Clin Oncol"},{"key":"R24-6-20210212","first-page":"411","article-title":"PET with O-(2-18F-fluoroethyl)-L-tyrosine in peripheral tumors: first clinical results","volume":"46","author":"Pauleit","year":"2005","journal-title":"J Nucl Med"},{"key":"R25-6-20210212","first-page":"1754","article-title":"Evaluation of 3\u2032-deoxy-3\u2032-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice","volume":"45","author":"Sugiyama","year":"2004","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0b013e328313b7bc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:14:37Z","timestamp":1786040077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006231-200901000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e328313b7bc","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}